Chewy Threatens Modern Animal Margins

Chewy matters because it can attack the most price sensitive part of Modern Animal’s revenue stack without building a better clinic. Modern Animal gets only about 12% of revenue from memberships and about 88% from services, diagnostics, procedures, and pharmacy, so a rival that pulls away prescription orders or uses low cost exams to win the household relationship can squeeze the profit pool that funds clinic buildout and debt service.

• Chewy Vet Care pairs clinics with 24/7 virtual advice, optional unlimited exam plans, and Chewy’s existing prescription fulfillment engine. That makes the offer feel less like a standalone vet office and more like a bundled care plus commerce subscription, which is especially potent in states where Modern Animal is expanding, including Texas and Colorado.
  1 sacra 2 chewy 4 chewy
• The margin pressure is most acute in pharmacy. Drug margins typically make up 15% to 20% of clinic revenue, and Modern Animal is explicitly building its own pharmacy and e-commerce layer to defend that pool. If Chewy wins the refill workflow, Modern Animal keeps the labor intensive visit while losing one of the cleaner revenue streams attached to it.
  1 sacra
• This is different from competition with Bond Vet or Small Door. Those players mostly compete clinic against clinic. Chewy brings more than 20 million active customers, a national fulfillment network, and a lower cost way to keep pet owners inside its app between visits. That scale can support sharper pricing even if the clinic itself is only part of the business.
  1 sacra 4 chewy 5 sacra

The next phase of competition will center on who owns the ongoing pet relationship, not just the exam room. Modern Animal is moving in that direction by adding pharmacy, e-commerce, and more software leverage inside its network. The stronger that layer becomes, the less exposed the company is to a retailer using low price care as a funnel into higher frequency prescription and product spend.